Janssen Biotech Inc.

04/11/2024 | Press release | Distributed by Public on 04/11/2024 06:49

Unique molecular properties of nipocalimab enabling differentiated potential in treating generalized myasthenia gravis to be presented at American Academy of Neurology's 2024[...]